<乌鸦传媒>Substantial Improvement in Vitiligo With Topical JAK Inhibitor About 30% of patients had 75% clearance after 6 months, half had 50% clearance Nov 06, 2021
<乌鸦传媒>Early Success With New Target in Atopic Dermatitis Inhibition of T乌鸦传媒-related inflammation leads to rapid improvement in disease activity Nov 05, 2021
<乌鸦传媒>Topical PDE4 Inhibitor Impresses in Trial of Seborrheic Dermatitis Rapid, persistent improvement in body surface area, itch, other symptoms with roflumilast Nov 04, 2021
<乌鸦传媒>How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<乌鸦传媒>Botox Doc's License Suspended Over Breast, Penis Enhancement Harms One patient allegedly required two surgeries to fix penile enhancement gone wrong Oct 21, 2021
<乌鸦传媒>FDA to Make Isotretinoin Prescribing Gender Neutral Revision to risk management program dissociates gender from reproductive categories Oct 18, 2021
<乌鸦传媒>Is Private Equity a Dangerous Employer? Firms' investments in healthcare continue to expand, at what cost? Oct 14, 2021
<乌鸦传媒>Case: VEGFR Inhibition in Merkel Cell Carcinoma Patient Disease stabilized after post-chemotherapy progression of the aggressive neuroendocrine cancer Oct 11, 2021
<乌鸦传媒>FDA Warns on Needle-Free Injection Devices for Facial Fillers Serious injuries and "irreversible" harm to skin, lips, and eyes reported with unapproved devices Oct 08, 2021
<乌鸦传媒>FDA Issues Orders Clarifying Rules for Marketing Sunscreens But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
<乌鸦传媒>In RA, Little Risk for Recurrent Cancer With Biologic Treatment Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<乌鸦传媒>FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis Significant skin clearance, reduced itch in majority of patients treated with ruxolitinib cream Sep 22, 2021
<乌鸦传媒>Adjuvant Pembrolizumab Boosts Recurrence-Free Survival in High-Risk Melanoma Also, fewer cases of distant recurrences in KEYNOTE-716 trial Sep 19, 2021
<乌鸦传媒>What's Causing Cancer Patient's Joint Pain While on Checkpoint Inhibitor? Here is how clinicians diagnosed this rare inflammatory side effect Aug 30, 2021
<乌鸦传媒>Oral Drug Active in Teens With Atopic Dermatitis Significant improvement at 12 weeks in 42-46% by one index, 68-72% by another Aug 24, 2021
<乌鸦传媒>Dual IL-17 Inhibitor Achieves Deep Responses in Hidradenitis Suppurativa Bimekizumab outclasses placebo, compares favorably with adalimumab Aug 20, 2021
<乌鸦传媒>Adalimumab Adds to Surgery Benefits for Hidradenitis Suppurativa Significantly higher response rates before and after surgery with biologic agent Aug 18, 2021
<乌鸦传媒>JAK Inhibitor Tops Mab for Eczema New disease-modifying treatment option on the horizon Aug 04, 2021
<乌鸦传媒>Third Dose a Charm in Israel? Door-to-Door 'Goons'; Cervids Catch COVID, Too! A daily roundup of news on COVID-19 and the rest of medicine Jul 30, 2021
<乌鸦传媒>Acne Takes a Toll on Women's Mental Health, Quality of Life Almost half reported self-consciousness, adverse effects on professional, social, personal lives Jul 28, 2021
<乌鸦传媒>Rates of Serious Infection Differ Among Psoriasis Therapies Low overall rate, small differences versus etanercept reference, large French study showed Jul 22, 2021
<乌鸦传媒>FDA Approves IVIG for Dermatomyositis Octagam 10% lands indication for adults following results of ProDERM trial Jul 20, 2021
<乌鸦传媒>Shingles Risk Slashed in IBD Patients After Vaccine Study found certain medications also showed lower incidence rates Jul 20, 2021
<乌鸦传媒>Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
<乌鸦传媒>COVID Surges Emerge; FDA Warns About Chantix; Lions, Tigers, Bears Get Vaxxed A daily roundup of news on COVID-19 and the rest of medicine Jul 06, 2021
<乌鸦传媒>Target TNF or IL-12/23 in Psoriatic Arthritis? Both TNF inhibitors and ustekinumab were effective in real-world use Jun 30, 2021
<乌鸦传媒>Start Thinking 'Cure'; One More Hug; Mortgages and Breast Cancer Survival News, features, and commentary about cancer-related issues Jun 16, 2021
<乌鸦传媒>Physician Organizations Challenge PA Name Change The AMA and AOA release statements against the rebrand Jun 09, 2021
<乌鸦传媒>Adjuvant Anti-PD-1 Misses on OS in High-Risk Melanoma But pembrolizumab topped active controls for relapse-free survival Jun 07, 2021
<乌鸦传媒>Lymph Node Findings on PET: Cancer or COVID Vaccine? Post-jab radiotracer uptake "could prompt unnecessary biopsies and treatments" May 26, 2021
<乌鸦传媒>Bad Day Sunshine: Benzene Found in Many Sun Care Products Valisure also detected the carcinogen in hand sanitizers earlier this year May 26, 2021
<乌鸦传媒>Methotrexate Impairs COVID Vax Response Can extra vaccine doses or discontinuing drug benefit patients with immune-mediated diseases? May 25, 2021
<乌鸦传媒>Unhealthy Quest for Lighter Skin Fuels Bleaching Epidemic Breaking the centuries-old cycle of myths about skin color May 25, 2021
<乌鸦传媒>Plaque Psoriasis Drug Shows Promise for Psoriatic Arthritis Monoclonal antibody targets the IL-23 p19 subunit May 20, 2021
<乌鸦传媒>Novel Immunotherapy Boosts Melanoma Outcomes Adding LAG-3 checkpoint inhibitor to nivolumab extended PFS in patients with advanced disease May 19, 2021
<乌鸦传媒>For Safety, One Biologic a Winner in Psoriasis, Psoriatic Arthritis Lower hospitalization rates compared with other biologics or small molecule therapies May 19, 2021
<乌鸦传媒>Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgaris Sustained complete response rate four times higher with anti-CD20 antibody May 19, 2021
<乌鸦传媒>Is This the Most TikTok'd COVID Vaccine Side Effect? Dermatologists say there's no issue: 'Happy filling, happy vaccinating' May 12, 2021
<乌鸦传媒>No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
<乌鸦传媒>Doubling Down on Immunotherapy in Advanced Melanoma Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
